Skip to content

Dog Assisted Therapy Program for Children With ADHD

Dog Assisted Therapy Program for Children With Attention Deficit Hyperactivity Disorder: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06496685
Acronym
DOGAD
Enrollment
36
Registered
2024-07-11
Start date
2018-12-01
Completion date
2023-04-27
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Disorder With Hyperactivity, Animal Assisted Therapy

Keywords

Animal Assisted Therapy, Attention Deficit Disorder with Hyperactivity, Children, Primary Health Care Center, Psychotherapy, Psychiatry

Brief summary

The purpose of this study was to evaluate the efficacy of AAT intervention in children with Attention Deficit Hyperactivity Disorder (ADHD), in terms of improving functionality, ADHD-associated symptoms, attention and working memory. Participants were recruited from a community Child and Adolescent Mental Health Service and a Primary Health Care Center. These objectives were accomplished through a multicenter, randomized clinical trial, open-label, two-arm study of AAT for children with ADHD.

Detailed description

The purpose of the present study was to evaluate the efficacy of Animal Assisted Therapy (with therapy dogs) in in children with Attention Deficit Hyperactivity Disorder (ADHD). The investigators conducted a multicenter, randomized, controlled, open-label, two-arm clinical trial. Thirty-six children aged 7-12 diagnosed with ADHD were randomized in two groups. Experimental group: 14 animal assisted therapy (AAT) psychoeducational sessions (once-a-week, 60 minutes) + treatment as usual and control group: treatment as usual. Participants were recruited from a community Child and Adolescent Mental Health Service and a Primary Health Care Center. The investigators evaluated changes on functionality, ADHD-associated symptoms, attention and working memory at pre-treatment and post-treatment. Assessment included intelligence test, ADHD symptoms referred by parents and teacher's (Conners Rating Scale), attention measures (Conners Continuous Performance Test (CPT-3) and children's functioning (Children's Global Assessment Scale (CGAS)).

Interventions

A structured AAT program and usual treatment in Experimental group.

Sponsors

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants were recruited from a community Child and Adolescent Mental Health Service and a Primary Health Care Center. And randomized in two groups.

Eligibility

Sex/Gender
ALL
Age
7 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Age between 7 and 12 years old (included). * Diagnosis of ADHD confirmed at the Child and Adolescent Mental Health Service. * Intelligence quotient of 80 or higher. * Delivery of the information sheet and signature of the informed consent.

Exclusion criteria

* If in the initial interview they declared having allergy or fear of dogs. * History of aggression towards animals. * Co-morbidity with other disorders (conduct disorders, autism spectrum disorders, anxiety disorder or depression). * If the treatment regimen was modified during the intervention period.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Children's Global Assessment Scale (CGAS) at 14 weeks.This scale was administered at baseline and at week 14It is a numerical scale to rate the overall functioning of young people under 18 years of age. Scores range from 1 to 100. A higher score indicates better functioning.
Change from baseline Clinical Global Impression - Severity Scale (CGI-S) at 14 weeksThis scale was administered at baseline and at week 14Is an instrument for measuring symptom severity of patients with mental disorders. Uses a single item on a Likert scale of seven values from 1= Normal, not at all ill to 7= Among the most extremely ill patients.

Secondary

MeasureTime frameDescription
Change from baseline Wechsler Intelligence Scale for Children (WISC-IV) at 14 weeks.This scale was administered at baseline and at week 14This instrument measures intellectual ability of children from 6 to 16 years. It was developed to provide an overall measure of general cognitive ability, and measures of intellectual functioning in Verbal Comprehension, Perceptual Reasoning, Working Memory and Processing Speed. The full version of the WISC-IV has 15 subtests, only ten are considered core, and used more often when testing intelligence.
Change from baseline Conners' Continuous Performance Test 3rd Edition (Conners CPT 3) at 14 weksThis test was administered at baseline and at week 14This test is a task-oriented computerized assessment of attention-related problems in individuals aged 8 years and older. By indexing the respondent's performance in areas of inattentiveness, impulsivity, sustained attention and vigilance.

Other

MeasureTime frameDescription
Change from baseline Conners Rating Scales Revised at 14 weeks.This scale was administered at baseline and at week 14In this study we used the short parents' version (27 items) and teachers' version (28 items). The scale is divided into 4 subscales: oppositional, inattention, hyperactivity -impulsivity and ADHD Index. Each item is scored from 0 to 3 (0= not true, 3= is always true). A typical score ≥70 indicates the presence of alterations in the subscale.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026